Disease · MONDO_0033821
Trials11
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.
1 to 11 of 11
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05110001 | Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction | Phase 3 | 330 | 2026-01-30 | Acanthamoeba Keratitis, Fungal Keratitis | CHLORHEXIDINE GLUCONATE, MOXIFLOXACIN, NATAMYCIN, ROSE BENGAL FREE ACID | Its record names the disease | ClinicalTrials.gov |
| NCT00996736 | Mycotic Ulcer Treatment Trial I | Phase 3 | 323 | 2013-12-11 | Corneal Ulcer, Eye Infections, Fungal | NATAMYCIN, VORICONAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT02570321 | Cross-linking for Corneal Ulcers Treatment Trial | Phase 3 | 147 | 2024-08-27 | Corneal Ulcer, Infectious Keratitis, Bacterial Ulcer, Fungal Ulcer | AMPHOTERICIN B, MOXIFLOXACIN, NATAMYCIN | Its record names the disease | ClinicalTrials.gov |
| NCT02731638 | Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers | Phase 3 | 70 | 2019-10-01 | Corneal Ulcer, Fungal Keratitis | NATAMYCIN, VORICONAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT06658002 | Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A | Phase 3 | 150 | Fungal Keratitis, Corneal Ulcer | CYCLOSPORINE, NATAMYCIN | Its record names the disease | ClinicalTrials.gov | |
| NCT05655689 | The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study | 123 | Bacterial Keratitis, Fungal Keratitis, Mixed Bacterial and Fungal Keratitis, Microbial Keratitis | CEFTAZIDIME, GENTAMICIN, MOXIFLOXACIN, NATAMYCIN, VANCOMYCIN, VORICONAZOLE | Its record names the disease | ClinicalTrials.gov | ||
| NCT06463678 | Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis | Phase 2 | 60 | Fungal Keratitis | POVIDONE-IODINE | Its record names the disease | ClinicalTrials.gov | |
| NCT03230058 | Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis | Phase 2/3 | 55 | Infection, Fungal | NATAMYCIN, VORICONAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT07557966 | Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis | Not applicable | 40 | Safety, Efficacy, Intrastromal Injection, Fluconazole, Treatment, Fungal Keratitis | FLUCONAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT03138785 | UVX as an Adjuvant in the Treatment of Fungal Keratitis | Not applicable | 20 | Treatment | ITRACONAZOLE, LEVOFLOXACIN, VORICONAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT05489510 | PXL-Platinum 330 in Eyes With Corneal Thinning Conditions | Phase 1/2 | 0 | Corneal Thinning, Keratoconus | RIBOFLAVIN | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0033821/trials